Introduction
============

Synovial sarcoma is a malignant mesenchymal tumor of uncertain histogenesis. It may be biphasic, monophasic, or poorly differentiated \[[@B1]\]. Synovial sarcoma is a rare entity representing 5% to 10% of all soft tissue sarcomas, typically occurring around the joints, mainly the knee \[[@B2],[@B3]\]. Occasionally, it arises in the head and neck \[[@B4],[@B5]\], lungs \[[@B6]-[@B8]\], heart \[[@B9]\], retroperitoneum \[[@B10]\], prostate \[[@B11]\] and intra-neurally \[[@B12]\]. There are few cases reported of synovial sarcoma arising in the gastrointestinal tract. We report the case of primary synovial sarcoma arising in the ileum of a 29-year-old woman. Our patient\'s tumor displayed morphologic features and immunohistochemical staining consistent with this disease. We believe that our case is the first reported case of monophasic synovial sarcoma arising from the ileum.

Case presentation
=================

A 29-year-old Saudi woman presented to our Emergency Room with a five-day history of epigastric and lower abdominal pain associated with lower abdominal and pelvic fullness that she attributed to fibroids. The pain was intermittent, colicky in nature and associated with nausea and vomiting. She denied any history of fever and there had been no change in her bowel habits or urinary symptoms. For several months she had been followed up regularly at the gynecology clinic due to the lower abdominal heaviness and distension. Her gynecological history revealed a nulliparous woman with no vaginal bleeding. Her medical history was significant for epilepsy since childhood, which was well controlled by medication, and a laparoscopic appendectomy one year ago. On examination, she was alert and conscious. Her vital signs were stable. Her abdomen was distended with a palpable pelvic-abdominal mass that was hard, non-tender and slightly mobile. Her liver and spleen were within the normal range and she had normal bowel sounds. No lymph nodes were enlarged and digital rectal examination revealed no abnormalities.

A computed tomography (CT) scan of her abdomen and pelvis showed a pelvic/abdominal mass adjacent to the distal small bowel loops separate from the uterus and ovaries, heterogeneously enhancing, measuring roughly 65 × 99 mm with multiple areas of necrosis (Figure [1A, B](#F1){ref-type="fig"}). A CT scan of her chest showed indeterminate multiple bilateral subpleural 2 mm to 4 mm lung nodules, too small to biopsy.

![**(A, B) Computed tomography (CT) axial and coronal cuts showing the pelvic/abdominal heterogeneous mass with areas of necrosis in addition to ascites**.](1752-1947-6-83-1){#F1}

The case was discussed by the multidisciplinary tumor board and the advice was to confirm the diagnosis to eliminate the possibility of an ovarian origin of the tumor because of its very close proximity.

Surgical exploration was indicated due to the finding of a large mass that was composed of a cystic and also a large solid component that needed to be investigated to eliminate the possibility of lymphoma or tuberculosis, which is quite common in our population. However, there was some radiological confusion about the origin of this mass and to some colleagues it was necessary to confirm it with a histological biopsy. For this reason, our patient underwent diagnostic laparoscopy, which showed a moderate amount of ascetic fluid with a large mass in the lower abdomen. When a biopsy was attempted, a large vein on the mass ruptured and bleeding made visualization extremely difficult. Therefore, the procedure was converted to an open one through a small lower midline incision. A 10 × 10 cm mass arising from the terminal ileum, occupying the pelvis and reaching to the umbilical area was found.

The uterus, ovaries and the urinary bladder were not involved. After a minimal dissection the tumor was excised with 10 cm free margins of small bowel and primary side-to-side anastomosis was performed. Our patient tolerated the procedure very well and her recovery period was unremarkable. She was discharged home on the seventh post-operative day. She was reviewed on an out-patient basis by our colleagues in radio-oncology and due to the radical nature of the surgery she was not offered any adjuvant treatment. She is still being followed up by our surgical oncology team and has shown no evidence of local or distant metastasis based on clinical and CT scan results after 24 months of follow-up.

Gross pathology revealed a segment of small bowel measuring 17 × 2 cm. It was adherent to a portion of ascending colon. An 8 × 7 × 3 cm white solid mass with a homogeneous cut surface was bulging from the serosal side of the small bowel; it was 4 cm away from the proximal resection margin. The tumor was adherent to the large bowel but not infiltrating it grossly. Few lymph nodes were identified within the mesenteric fat. Microscopy showed that the tumor was composed of cellular spindle cells with a mild to moderate degree of pleomorphism arising from the small bowel wall and mainly involving the submucosa, muscularis propria and serosa. Focal mucosal erosion was identified. The tumor cells showed a moderate amount of eosinophilic cytoplasm, evenly distributed nuclear chromatin and a few conspicuous nuclei (Figure [2A, B](#F2){ref-type="fig"}). The mitotic count was one to two per 10 high-power fields. A metastatic focus was identified within a single mesenteric lymph node (Figure [2C](#F2){ref-type="fig"}).

![**(A) A spindle cell neoplasm arising from the wall of the small bowel and pushing the mucosa toward the lumen, (B) spindle cells with mild to moderate degree of pleomorphism and few conspicuous nuclei, and (C) a spindle cell metastatic focus in a mesenteric lymph node (hematoxylin and eosin; (A) ×2, (B) ×20, (C) ×4)**.](1752-1947-6-83-2){#F2}

Immunohistochemical testing results showed that the tumor was positive for S100, epithelial membrane antigen (EMA), B cell lymphoma 2 (Bcl 2), and vimentin (Figure [3A-C](#F3){ref-type="fig"}). CD99 tests were negative (Figure [3F](#F3){ref-type="fig"}) and CDl17 tests were positive (Figure [3E](#F3){ref-type="fig"}), in addition to calretinin (focal) and synaptophysin (focal), and CD56 (few cells). The specimen tested negative for CD34, CAM5.2, cytokeratin 7, 20, and 5/6 (Figure [3H](#F3){ref-type="fig"}), cytokeratin AE1/AE3, neuron-specific enolase (NSE), CD31, desmin (Figure [3G](#F3){ref-type="fig"}), chromogranin, smooth muscle actin (SMA), HMB45, factor 8, Ber/EB4, and melan-A.

![**Immunohistochemical staining. (A)**S100, ×20; **(B)**epithelial membrane antigen (EMA), ×20; **(C)**B cell lymphoma 2 (Bcl 2), ×40; **(D)**vimentin, ×20; **(E)**CD117, ×20; **(F)**CD99, ×20; **(G)**desmin, ×20; **(H)**cytokeratin (CK)5/6, ×20.](1752-1947-6-83-3){#F3}

A cytogenetic study of the specimen was conducted on a formalin fixed paraffin embedded tumor sample. The result of a real-time polymerase chain reaction (RT-PCR) procedure for synovial sarcoma-associated fusion transcript (SYT-SSX1 and SYT-SSX2) was negative.

Our patient was seen periodically in our surgical oncology clinic and she has remained disease free for 24 months with no clinical or radiological evidence of local recurrence.

Discussion
==========

Gastrointestinal sarcoma accounts for 0.1% to 3% of all gastrointestinal (GI) malignancies and approximately 10% of all sarcomas \[[@B13],[@B14]\]. In the ileum, the majority of malignant sarcomas are GI stromal tumors (GISTs) \[[@B15]\]. To the best of our knowledge there have been only 27 reported cases of synovial sarcoma arising in the GI tract, and none of them in the ileum \[[@B16]-[@B32]\]. All of them shared the diagnostic histology and immunohistochemical features of synovial sarcoma. In 64% of the cases, the characteristic (X; 18) translocation was identified. We made the diagnosis in our patient\'s case based on the histology of monophasic synovial sarcoma and the Immunohistochemical features. Although the molecular assay results were negative for SYT-SSX1 and SYT-SSX2, the combined histological and Immunohistochemical profiles were highly characteristic of monophasic synovial sarcoma.

The median age at diagnosis was 41.5 years (range, 14 to 75 years). There is no significant sex predilection with a male to female ratio of 1:1.15. There are 11 and 12 cases of GI tract synovial sarcoma arising from the esophagus (including one from the gastroesophageal junction) and stomach, respectively, representing the most common sites. The presenting symptoms were pain, obstruction or bleeding. The histological subtypes were monophasic in 15 patients and biphasic in 11 patients including two patients with a poorly differentiated component. The remaining patients\' histological subtypes have not been reported. All of the reported cases were treated surgically. The number of patients who received adjuvant chemotherapy or radiotherapy or both are five, four and three, respectively. Only one patient had metastasis at first presentation. Billings \[[@B25]\] reported a patient with gastric synovial sarcoma with multiple liver metastases who died of the disease after six months. The survival period after diagnosis of all reported cases ranged from 1 to 224 months (Table [1](#T1){ref-type="table"}).

###### 

Summary of the reported cases of primary synovial sarcoma in the gastrointestinal tract

  Author, year, reference                        Location                          Presenting symptoms                                      Age, years   Gender   Size, cm   Gross features          Histologic type                                     Translocation    Treatment     Status and follow-up, months
  ---------------------------------------------- --------------------------------- -------------------------------------------------------- ------------ -------- ---------- ----------------------- --------------------------------------------------- ---------------- ------------- --------------------------------------
  Palmer *et al.*1983 \[[@B16]\]                 Esophagus                         Dysphagia                                                75           F        2.5        Polypoid                Biphasic                                            \-               S+Rad         DOD, 24
  Amr *et al.*1984 \[[@B17]\]                    Esophagus                         Dysphagia                                                25           M        5          Polypoid                Biphasic                                            \-               S+Rad         AWOD, 36
  Bloch *et al.*, 1987 \[[@B18]\]                Esophagus                         Dysphagia, dyspnea                                       15           M        7          Polypoid                Biphasic                                            \-               S+Rad         AWOD, 36
  Pulpiero *et al.*, 1988 \[[@B19]\]             Esophagus                                                                                  24           M                                           Biphasic                                            \-               S             NR
  Caldwell *et al.*, 1991 \[[@B20]\]             Esophagus                                                                                  29           F                                           NR                                                  \-               S+Rad+Chemo   AWOD, 195
  Perch *et al.*, 1991 \[[@B21]\]                Esophagus                                                                                  15           M                                           Biphasic                                            \-               S+Rad         AWOD, 5 to 6 years after surgery
  Antón-Pacheco *et al.*, 1996 \[[@B22]\]        Esophagus                         Dysphagia, weight loss                                   14           F        7          Polypoid                Biphasic                                            \-               S+Chemo+Rad   AWOD, 30
  Habu S *et al.*1998 \[[@B23]\]                 Esophagus                         Sensation of something stuck in the throat               20           M        8          Polypoid                Biphasic                                            \-               S+Chemo+Rad   AWOD, 20
  Bonavina *et al.*, 1998 \[[@B24]\]             Esophagus                         Achalasia                                                63           F                   Polypoid                NR                                                  \-               \-            \-
  Billings *et al.*, 2000 \[[@B25]\]             Gastroesophageal junction         Incidental finding for pyloric stenosis                  47           M        5.2        Polypoid                Biphasic                                            t(X; 18)         S             AWOD, 21
  Billings *et al.*, 2000 \[[@B25]\]             Stomach                           Abdominal pain, nausea, vomiting and rectal bleeding     55           F        16         Spherical, intramural   Biphasic and PDSS                                   t(X; 18)         S             DOD, 6
  Chan *et al.*, 2004 \[[@B26]\]                 Jejunum                           Epigastric pain, vomiting and fever                      28           M        15         Polypoid, intramural    Monophasic                                          t(X; 18), SSX2   S             DOD, 1
  Butori *et al.*, 2006 \[[@B27]\]               Esophagus                         Dysphagia                                                72           F        11         Polypoid                Biphasic                                            t(X; 18)         S+Chemo       6
  Akhunji *et al.*, 2007 \[[@B28]\]              Stomach                           Epigastric pain                                          42           M        11                                 Biphasic                                            t(X; 18)         S+Chemo       DOD, 24
  Parfitt *et al.*, 2007 \[[@B29]\]              Colon                             Rectal bleeding                                          32           M        2          Polypoid                Monophasic                                          t(X; 18)         S             5
  Schreiber-Fracklam *et al.*, 2007 \[[@B30]\]   Distal duodenum                   Abdominal pain                                           39           F        5          Polypoid                Monophasic                                          t(X; 18), SSX2   S+Chemo       Recurrence 8 months after surgery
  Makhlouf *et al.*, 2008 \[[@B32]\]             Stomach                                                                                    67           F        0.8                                Monophasic                                          t(X; 18)         S             AWOD, 12
  Makhlouf *et al.*, 2008 \[[@B32]\]             Stomach                                                                                    49           M        2                                  Monophasic with a poorly differentiated component   t(X; 18)         S             DOD, omental metastasis, 29
  Makhlouf *et al.*, 2008 \[[@B32]\]             Stomach                                                                                    68           F        2                                  Monophasic                                          t(X; 18)         S             AWOD, 22
  Makhlouf *et al.*, 2008 \[[@B32]\]             Stomach                                                                                    29           M        2.8                                Monophasic                                          t(X; 18)         S             AWOD, 224
  Makhlouf *et al.*, 2008 \[[@B32]\]             Stomach, gastrodudenal junction                                                            54           F        3                                  Monophasic                                          t(X; 18)         S             Recent case
  Makhlouf *et al.*, 2008 \[[@B32]\]             Stomach                                                                                    58           F        3                                  Monophasic                                          t(X; 18)         S             AWOD, 21
  Makhlouf *et al.*, 2008 \[[@B32]\]             Stomach                                                                                    37           F        4                                  Monophasic                                          t(X; 18)         S             Local recurrence, re-excised. DOC 48
  Makhlouf *et al.*, 2008 \[[@B32]\]             Stomach                                                                                    50           M        6                                  Monophasic                                          t(X; 18)         S+Chemo       Alive with recurrence, 6
  Makhlouf *et al.*, 2008 \[[@B32]\]             Stomach                                                                                    42           M        8          Polypoid                Biphasic                                            t(X; 18)         S+Chemo       DOD, 25
  Makhlouf *et al.*, 2008 \[[@B32]\]             Stomach                                                                                    66           F        15         Polypoid                Monophasic                                          t(X; 18)         S             Lost to follow-up
  Company *et al.*, 2009 \[[@B31]\]              Proximal duodenum                 Weight loss asthenia anorexia, nausea, epigastric pain   69           F        8          Spherical, intramural   Monophasic                                          t(X; 18)         S             Died due to complications, 1
  Present case, 2010                             Ileum                             Abdominal pain, distension and heaviness                 39           F        8          Intramural              Monophasic                                          \-               S             AWOD, 6

The second case reported by Billings \[[@B25]\] could represent a metastatic focus of a primary neck tumor as it showed the same histopathological features.

AWOD = alive without evidence of disease; AWD = alive with residual disease; Chemo = chemotherapy; DOC = died of other cause; DOD = died of disease; NR = not reported; Rad = radiotherapy; S = surgery; SSX = synovial sarcoma-associated fusion transc; PDSS = Poorly difrentiated synovial sarcoma

In soft tissue synovial sarcoma, numerous studies over the years have reported that it is a high grade malignancy with a high rate of metastasis leading to death; 10-year survival rates between 24% to 68% and 11% to 56% have been reported \[[@B27],[@B33]\].

In the article by Bergh *et al.*\[[@B33]\], the investigators divided patients with synovial sarcoma into low-risk and high-risk groups depending on their age, tumor size and grade as follows: low-risk group (patient age \< 25 years, tumor size \< 5 cm, and no histologic evidence of poorly differentiated tumor); high-risk group (patient age approximately 25 years, tumor size approximately 5 cm, and poorly differentiated tumor). The question is, can we apply the same risk factors to patients with GI synovial sarcoma? To answer such a question we need to diagnose more cases and collect more data about the already published cases to study the behavior of this disease entity in the GI tract, as well as in other parts of the body. Presently, the evidence suggests adequate primary surgery is essential to both local control and outcome. The other question that one may ask: why do these tumors shift to unusual sites and different tissues? The honest answer, at least at this time, would by that we do not yet know the exact mechanism for such a shift. We are involved in a larger research study to investigate the increased incidence of sarcomas in the Saudi population, particularly in the northern region, which is close to the military activities of both Gulf wars and the military activities in Iraq over the last decade.

Conclusions
===========

In general, sarcomas are relatively rare tumor entities, particularly in the GI tract. For many reasons, it is easy to confuse the subtypes of sarcomas, including the histological similarities, the experience of the centers dealing with such tumors, proper handling, and staining and immunohistochemical findings. It is also likely to mistake such extremely rare presentations of an unusual malignancy such as synovial sarcoma for relatively more common tumors such as GISTs, which can present with more or less the same clinical scenario. The clinical importance comes from the fact that sarcomas carry a slightly worse prognosis and need a closer follow-up not to miss any sign of local recurrence or distant metastasis. We also believe that any rare presentation of any subtype of sarcoma should be carefully reported and documented to add to the relatively small pool of cases in comparison with other common malignant tumors, in order to increase our knowledge and understanding of sarcoma in general.
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